Multimodal Analysis of FDA Drug Safety Communications: Lessons from Zolpidem Aaron S. KesselheimMichael S. SinhaGerald J. Dal Pan Special Article 13 July 2019 Pages: 1287 - 1295
Transparent Reporting on Research Using Unstructured Electronic Health Record Data to Generate ‘Real World’ Evidence of Comparative Effectiveness and Safety Shirley V. WangOlga V. PattersonAndrew Bate Leading Article 26 August 2019 Pages: 1297 - 1309
Benefit-Risk Assessment of Alogliptin for the Treatment of Type 2 Diabetes Mellitus Kohei KakuKoichi KisanukiTakashi Oohira Review Article Open access 25 October 2019 Pages: 1311 - 1327
Prevalence of Medication Errors Among Paediatric Inpatients: Systematic Review and Meta-Analysis Peter J. GatesMelissa T. BaysariJohanna I. Westbrook Systematic Review 09 July 2019 Pages: 1329 - 1342
Patient Registries: An Underused Resource for Medicines Evaluation Patricia McGettiganCarla Alonso OlmoPeter G. M. Mol Original Research Article Open access 13 July 2019 Pages: 1343 - 1351
Correction to: Patient Registries: An Underused Resource for Medicines Evaluation Patricia McGettiganCarla Alonso OlmoPeter G. M. Mol Correction 05 September 2019 Pages: 1353 - 1353
Non-Vitamin K Antagonist Oral Anticoagulants and Angioedema: A Cohort and Case-Crossover Study John G. ConnollySebastian SchneeweissJoshua J. Gagne Original Research Article 18 July 2019 Pages: 1355 - 1363
A Novel Approach to Visualize Risk Minimization Effectiveness: Peeping at the 2012 UK Proton Pump Inhibitor Label Change Using a Rapid Cycle Analysis Tool Rachel E. SobelWilliam BlackwellAndrew Bate Original Research Article 31 July 2019 Pages: 1365 - 1376
Identifying the DEAD: Development and Validation of a Patient-Level Model to Predict Death Status in Population-Level Claims Data Jenna M. RepsPeter R. RijnbeekPatrick B. Ryan Original Research Article Open access 03 May 2019 Pages: 1377 - 1386